Ayeh Bani Saeid, Gabriele De Rubis, Kylie A Williams, Stewart Yeung, Dinesh Kumar Chellappan, Sachin Kumar Singh, Gaurav Gupta, Philip M Hansbro, Mohammad-Ali Shahbazi, Monica Gulati, Indu Pal Kaur, Hélder A Santos, Keshav Raj Paudel, Kamal Dua
The escalating prevalence of lung diseases underscores the need for innovative therapies. Dysbiosis in human body microbiome has emerged as a significant factor in these diseases, indicating a potential role for synbiotics in restoring microbial equilibrium. However, effective delivery of synbiotics to the target site remains challenging. Here, we aim to explore suitable nanoparticles for encapsulating synbiotics tailored for applications in lung diseases. Nanoencapsulation has emerged as a prominent strategy to address the delivery challenges of synbiotics in this context...
April 17, 2024: Chemico-biological Interactions